J C Fruchart|G Ailhaud - JoVE Visualize

Showing results (361-370 of 566) with videos related to

Pageof 57

Sort By:

Molecular and Cellular Endocrinology|September 1, 1994

Retinoids are positive effectors of adipose cell differentiationI Safonova, C Darimont, E Z Amri, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988

Lipoprotein abnormalities in chronic haemodialysis patientsD Parsy, M Dracon, C Cachera, et al.

Thrombosis Research|June 15, 1987

Analysis of phospholipid transfer during HDL binding to platelets using a fluorescent analog of phosphatidylcholineF Martin-Nizard, B Richard, G Torpier, et al.

Journal of Neurochemistry|May 1, 1992

Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo modelsM P Dehouck, P Jolliet-Riant, F Brée, et al.

Journal of Lipid Research|July 1, 1992

Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-IIIW J McConathy, J C Gesquiere, H Bass, et al.

Clinical Chemistry|January 1, 1979

Determination of amniotic fluid phospholipids by thin-layer chromatography, with use of a hydrogen flame ionization detectorA Martin-Ponthieu, N Porchet, J C Fruchart, et al.

Genetic Epidemiology|January 1, 1994

Sources of variability of human plasma apolipoprotein A-IV levels and relationships with lipid metabolismM Zaiou, S Visvikis, R Gueguen, et al.

Biochimica Et Biophysica Acta|March 12, 1991

Isolation and characterization of human Lp-B lipoprotein containing apolipoprotein B as the sole apolipoproteinJ M Bard, L Candelier, G Agnani, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1996

Alteration of the lipid and apolipoprotein contents of lipoprotein (a) in haemodialysis patientsV Hugue, M Kandoussi, H J Parra, et al.

Journal of Cardiovascular Pharmacology|November 27, 2002

Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cellsF Martin-Nizard, C Furman, P Delerive, et al.

Pageof 57

Showing results (361-370 of 566) with videos related to

Sort By:

Pageof 57

Molecular and Cellular Endocrinology|September 1, 1994

Retinoids are positive effectors of adipose cell differentiationI Safonova, C Darimont, E Z Amri, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1988

Lipoprotein abnormalities in chronic haemodialysis patientsD Parsy, M Dracon, C Cachera, et al.

Thrombosis Research|June 15, 1987

Analysis of phospholipid transfer during HDL binding to platelets using a fluorescent analog of phosphatidylcholineF Martin-Nizard, B Richard, G Torpier, et al.

Journal of Neurochemistry|May 1, 1992

Drug transfer across the blood-brain barrier: correlation between in vitro and in vivo modelsM P Dehouck, P Jolliet-Riant, F Brée, et al.

Journal of Lipid Research|July 1, 1992

Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-IIIW J McConathy, J C Gesquiere, H Bass, et al.

Clinical Chemistry|January 1, 1979

Determination of amniotic fluid phospholipids by thin-layer chromatography, with use of a hydrogen flame ionization detectorA Martin-Ponthieu, N Porchet, J C Fruchart, et al.

Genetic Epidemiology|January 1, 1994

Sources of variability of human plasma apolipoprotein A-IV levels and relationships with lipid metabolismM Zaiou, S Visvikis, R Gueguen, et al.

Biochimica Et Biophysica Acta|March 12, 1991

Isolation and characterization of human Lp-B lipoprotein containing apolipoprotein B as the sole apolipoproteinJ M Bard, L Candelier, G Agnani, et al.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 1, 1996

Alteration of the lipid and apolipoprotein contents of lipoprotein (a) in haemodialysis patientsV Hugue, M Kandoussi, H J Parra, et al.

Journal of Cardiovascular Pharmacology|November 27, 2002

Peroxisome proliferator-activated receptor activators inhibit oxidized low-density lipoprotein-induced endothelin-1 secretion in endothelial cellsF Martin-Nizard, C Furman, P Delerive, et al.

Pageof 57